RARE vs TSM
Ultragenyx (RARE) versus TSM (TSM) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
TSM (TSM) common stock.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
TSM does not have a complete income-statement cache yet.
RARE currently screens at market cap $2.79B. TSM currently screens at market cap $0.
Not investment advice. Open the RARE and TSM stock pages for the full models.
Not investment advice.